Elypta Company
Preventing cancer mortality by developing a metabolism-based liquid biopsy platform for early detection and monitoring
%20.jpg)
Founded Date:
2017
Investor Type:
For Profit
Estimated Revenue:
Less than $1M
Employee Number:
11-50
Industry:
PharmTech
Technology:
Small Molecules
Headquarters:
Stockholm, Stockholms Lan, Sweden
Funding Status:
Seed